17th International Symposium on Atherosclerosis (ISA 2015)
RAI Amsterdam *Amsterdam, NETHERLANDS Visit the Venue to read more
Translating Atherosclerosis Research into Novel Therapies for Humans
17th INTERNATIONAL SYMPOSIUM ON ATHEROSCLEROSIS
ISA2015 - A Clean Break From the Past, the Future Starts Now!
ISA 2015 is designed in a novel format that helps attendees to travel from the crystallized knowledge of today towards the edge of clinical innovation in atherosclerosis.
X-Change Sessions, Rapid Fire Arenas, I-Poster Area as a full digital experience, and with multilingual sessions, ISA2015 will become the condensation of future atherosclerosis education. Via structured Plenary State-of-the-Art & Controversies Sessions,
A Stage for Young Scientists
ISA 2015 offers a prominent stage to young scientists involved in basic science, translational studies and clinical trials. Present to a global audience and discuss your work with students and key opinion leaders.
World Class International Faculty
ISA2015 has succeeded to attract an international faculty that invariably consists of global leaders in the field of atherosclerosis research and cardiovascular medicine. Our faculty members will cover all relevant topics in current atherosclerosis research.
Full Digital Experience
ISA 2015 will fuse the real and digital world. All attendees will receive a 7”tablet to start their digital experience. This translates not only into less paper, but moreover into a convenient, information-rich digital journey. A journey that will start long before your arrival in Amsterdam.
Clinical & Translational: 4 Main Tracks
The ISA2015 committee has designed a scientific program that will address all relevant topics and developments in atherosclerosis and cardiovascular disease. ISA 2015 will explore four relevant themes: Dyslipidaemia, Pathogenesis, Prevention and Epidemiology of Atherosclerosis.
For the First Time In Four Languages
Sessions and Satellites are offered in 4 important global languages (English, Russian, Chinese, Spanish), since CVD is the leading cause of death and disease in each and every country of the world. Contributions to the fight against atherogenesis and its interventions come, and continue to come, from all corners of the globe.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
©2014 ISA 2015 Amsterdam